Orexin Receptor Type 1 (Hypocretin Receptor Type 1 or HCRTR1) – Pipeline Review, H1 2018
WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Orexin Receptor Type 1 - Pipeline Review, H1 2018”
Overview
Orexin Receptor Type 1 (Hypocretin Receptor Type 1 or HCRTR1) - Orexin receptor type 1 (Ox1R or OX1) is a protein that is encoded by the HCRTR1 gene. The orexin 1 receptor (OX1) is a G-protein coupled receptor that is highly expressed in projections from the lateral hypothalamus and is involved in the regulation of feeding behavior. OX1 selectively binds the orexin-A neuropeptide.
Click here for sample report @ https://www.wiseguyreports.com/sample-request/3079819-orexin-receptor-type-1-hypocretin-receptor-type-1
Major Key Players:
Chronos Therapeutics Ltd
Eisai Co Ltd
Heptares Therapeutics Ltd
Idorsia Ltd
Johnson & Johnson
Merck & Co Inc
Orexin Receptor Type 1 Industry Major Outlook
Pharmaceutical and Healthcare latest pipeline guide Orexin Receptor Type 1 - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Orexin Receptor Type 1 , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Orexin Receptor Type 1 (Hypocretin Receptor Type 1 or HCRTR1) pipeline Target constitutes close to 14 molecules. Out of which approximately 14 molecules are developed by Companies. The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 2, 7 and 3 respectively.
Orexin Receptor Type 1 pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Orexin Receptor Type 1 - Competitive Analysis
Key players are making innovative developments in Orexin Receptor Type 1 industry. The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Orexin Receptor Type 1.
The pipeline guide reviews pipeline therapeutics for Orexin Receptor Type 1 by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Orexin Receptor Type 1 therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Orexin Receptor Type 1 therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Orexin Receptor Type 1.
.Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/3079819-orexin-receptor-type-1-hypocretin-receptor-type-1
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Posted by
Vivian Dsena
on Tuesday April 03 2018, 5:31 AM EDT.
All trademarks acknowledged.
Filed under Uncategorized.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
